BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15300742)

  • 21. Acampomelic campomelic syndrome.
    Moog U; Jansen NJ; Scherer G; Schrander-Stumpel CT
    Am J Med Genet; 2001 Dec; 104(3):239-45. PubMed ID: 11754051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Increased nuchal translucency with normal karyotype].
    Senat MV; Frydman R
    Gynecol Obstet Fertil; 2007 Jun; 35(6):507-15. PubMed ID: 17521948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical breakpoint in a t(6;17) translocation case of acampomelic campomelic dysplasia.
    Walters-Sen LC; Thrush DL; Hickey SE; Hashimoto S; Reshmi S; Gastier-Foster JM; Pyatt RE; Astbury C
    Eur J Med Genet; 2014 Jul; 57(7):315-8. PubMed ID: 24821304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence to exclude SOX9 as a candidate gene for XY sex reversal without skeletal malformation.
    Kwok C; Goodfellow PN; Hawkins JR
    J Med Genet; 1996 Sep; 33(9):800-1. PubMed ID: 8880588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuchal translucency and nasal bone for trisomy 21 screening: single center experience.
    Monni G; Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C
    Croat Med J; 2005 Oct; 46(5):786-91. PubMed ID: 16158472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex-reversed acampomelic campomelic dysplasia with a homozygous deletion mutation in SOX9 gene.
    Chen SY; Lin SJ; Tsai LP; Chou YY
    Urology; 2012 Apr; 79(4):908-11. PubMed ID: 21962881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The implementation of first-trimester scanning at 10-13 weeks' gestation and the measurement of fetal nuchal translucency thickness in two maternity units.
    Pandya PP; Goldberg H; Walton B; Riddle A; Shelley S; Snijders RJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):20-5. PubMed ID: 7850584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
    Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R
    Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebro-fronto-facial syndrome (Dandy-Walker Variant and frontofacial dysmorphisms): report of the first case identified by increased nuchal translucency beyond 13(+6) weeks.
    Tonni G; Azzoni D; Ambrosetti F; de Felice C; Ventura A
    Congenit Anom (Kyoto); 2007 Jun; 47(2):68-71. PubMed ID: 17504390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
    Spencer K; Nicolaides KH
    BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Campomelic dysplasia with XY sex reversal: diverse phenotypes resulting from mutations in a single gene.
    Schafer AJ; Foster JW; Kwok C; Weller PA; Guioli S; Goodfellow PN
    Ann N Y Acad Sci; 1996 Jun; 785():137-49. PubMed ID: 8702120
    [No Abstract]   [Full Text] [Related]  

  • 32. Prenatal diagnosis of campomelic dysplasia due to
    Kayhan G; Calis P; Karcaaltincaba D; Tug E
    J Obstet Gynaecol; 2019 Nov; 39(8):1175-1176. PubMed ID: 31234679
    [No Abstract]   [Full Text] [Related]  

  • 33. Phenotype of five cases of prenatally diagnosed campomelic dysplasia harboring novel mutations of the SOX9 gene.
    Gentilin B; Forzano F; Bedeschi MF; Rizzuti T; Faravelli F; Izzi C; Lituania M; Rodriguez-Perez C; Bondioni MP; Savoldi G; Grosso E; Botta G; Viora E; Baffico AM; Lalatta F
    Ultrasound Obstet Gynecol; 2010 Sep; 36(3):315-23. PubMed ID: 20812307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic study of SOX9 in a case of campomelic dysplasia.
    Giordano J; Prior HM; Bamforth JS; Walter MA
    Am J Med Genet; 2001 Jan; 98(2):176-81. PubMed ID: 11223854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased first-trimester fetal nuchal translucency thickness in association with chondroectodermal dysplasia (Ellis-Van Creveld syndrome).
    Venkat-Raman N; Sebire NJ; Murphy KW; Carvalho JS; Hall CM
    Ultrasound Obstet Gynecol; 2005 Apr; 25(4):412-4. PubMed ID: 15717287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sonographic findings in a case of tetrasomy 9p associated with increased nuchal translucency and Dandy-Walker malformation.
    Nakamura-Pereira M; Cima LC; Llerena JC; Guerra FA; Peixoto-Filho FM
    J Clin Ultrasound; 2009 Oct; 37(8):471-4. PubMed ID: 19655321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Del(18p) syndrome with increased nuchal translucency in prenatal diagnosis.
    Kim YM; Cho EH; Kim JM; Lee MH; Park SY; Ryu HM
    Prenat Diagn; 2004 Mar; 24(3):161-4. PubMed ID: 15057945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased nuchal translucency with normal karyotype.
    Souka AP; Von Kaisenberg CS; Hyett JA; Sonek JD; Nicolaides KH
    Am J Obstet Gynecol; 2005 Apr; 192(4):1005-21. PubMed ID: 15846173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
    Pandya PP; Snijders RJ; Johnson S; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.